INC launches new consulting unit; Chemi says a saboteur got it banned in Canada;

> INC Research has launched a new business unit, Research Strategic Advisory Services, aimed to consult with drugmakers as they plot paths for development and commercialization. News

> Catalent is extending its partnership with Exelixis to supply the cancer drug CometriqT in the U.S. Story

> U.K. CMO Aesica Pharmaceutical says partnering with academia is getting more and more important for contractors looking to meet the changing demands of pharma clients. Article

> As drug delivery technology moves forward into new frontiers, CROs and CMOs are driving some of the most innovative thinking, Life Science Leader reports. More

> Canada's Chemi Pharmaceutical is blaming a sabotaging former employee for falsified results that got it suspended by the country's regulatory outfit. Item

> QPS has launched a joint venture with Intellim to create a new Japanese CRO. Report

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.